SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-168089
Filing Date
2009-08-07
Accepted
2009-08-07 07:22:10
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 616577
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9526
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9532
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2662
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2671
  Complete submission text file 0001193125-09-168089.txt   642398
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 09993537
SIC: 8731 Services-Commercial Physical & Biological Research